BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20162337)

  • 1. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model.
    Baltes S; Freund I; Lewis AL; Nolte I; Brinker T
    J Mater Sci Mater Med; 2010 Apr; 21(4):1393-402. PubMed ID: 20162337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.
    Glage S; Lewis AL; Mertens P; Baltes S; Geigle P; Brinker T
    Clin Transl Oncol; 2012 Jan; 14(1):50-9. PubMed ID: 22262719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
    Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
    Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A safety and toxicity assessment of the administration of multiple intracerebral injections of irinotecan or doxorubicin drug-eluting beads.
    Held N; Lewis AL; Hedrich HJ; Brinker T; Glage S
    Clin Transl Oncol; 2011 Oct; 13(10):742-6. PubMed ID: 21975337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery chemoembolization in a sheep model: Evaluation of performance and safety of irinotecan eluting beads (DEB-IRI).
    Baylatry MT; Pelage JP; Wassef M; Ghegediban H; Joly AC; Lewis A; Lacombe P; Fernandez C; Laurent A
    J Biomed Mater Res B Appl Biomater; 2011 Aug; 98(2):351-9. PubMed ID: 21656666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.
    Biondi M; Fusco S; Lewis AL; Netti PA
    J Mater Sci Mater Med; 2013 Oct; 24(10):2359-70. PubMed ID: 23797828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies.
    Forster RE; Tang Y; Bowyer C; Lloyd AW; Macfarlane W; Phillips GJ; Lewis AL
    Anticancer Drugs; 2012 Apr; 23(4):355-69. PubMed ID: 22241169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods.
    Hagan A; Caine M; Press C; Macfarlane WM; Phillips G; Lloyd AW; Czuczman P; Kilpatrick H; Bascal Z; Tang Y; Garcia P; Lewis AL
    Eur J Pharm Sci; 2019 Aug; 136():104943. PubMed ID: 31152772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer.
    Keese M; Gasimova L; Schwenke K; Yagublu V; Shang E; Faissner R; Lewis A; Samel S; Löhr M
    Int J Cancer; 2009 Jun; 124(11):2701-8. PubMed ID: 19165866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local implantation of doxorubicin drug eluting beads in rat glioma.
    Vinchon-Petit S; Jarnet D; Michalak S; Lewis A; Benoit JP; Menei P
    Int J Pharm; 2010 Dec; 402(1-2):184-9. PubMed ID: 20863875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study.
    Lemaire L; Roullin VG; Franconi F; Venier-Julienne MC; Menei P; Jallet P; Le Jeune JJ; Benoit JP
    NMR Biomed; 2001 Oct; 14(6):360-6. PubMed ID: 11599034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
    Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
    Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
    Desjardins A; Reardon DA; Herndon JE; Marcello J; Quinn JA; Rich JN; Sathornsumetee S; Gururangan S; Sampson J; Bailey L; Bigner DD; Friedman AH; Friedman HS; Vredenburgh JJ
    Clin Cancer Res; 2008 Nov; 14(21):7068-73. PubMed ID: 18981004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.
    Lewis AL; Dreher MR; O'Byrne V; Grey D; Caine M; Dunn A; Tang Y; Hall B; Fowers KD; Johnson CG; Sharma KV; Wood BJ
    J Mater Sci Mater Med; 2016 Jan; 27(1):13. PubMed ID: 26676859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
    Batchelor TT; Gilbert MR; Supko JG; Carson KA; Nabors LB; Grossman SA; Lesser GJ; Mikkelsen T; Phuphanich S;
    Neuro Oncol; 2004 Jan; 6(1):21-7. PubMed ID: 14769136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
    Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
    J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma.
    Gilbert MR; Supko JG; Batchelor T; Lesser G; Fisher JD; Piantadosi S; Grossman S
    Clin Cancer Res; 2003 Aug; 9(8):2940-9. PubMed ID: 12912940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.